Achla Gupta, PhD
img_Achla Gupta
ASSISTANT PROFESSOR | Pharmacological Sciences
My research interests include the investigation of G-protein coupled receptor heterodimerization/oligomerization using antibodies as tools. I have generated an antibody against mu-delta heterodimers using subtractive immunization. This antibody recognize mu-delta heterdimers by ELISA in vitro and as well as in vivo. I have also generated selective monoclonal antibodies against the N-terminal region of opioid receptors. We have used N-terminal selective antibodies to investigate the structural changes occurring during opioid receptor activation. Interestingly, antibody recognition was found to be modulated only by agonists and not antagonists in a dose-dependent manner. The antibodies were able to distinguish agonist-mediated conformational changes between wild-type and constitutively active mutant receptors. Based on these results, I have generated conformation-sensitive polyclonal antibodies against a similar region in the N-terminus of other members of the rhodopsin family (cannabinoid and adrenergic receptors). Interestingly, these antibodies were also able to recognize active conformations of the endogenous receptors. These antibodies provide a potential tool for identifying and characterizing new compounds of therapeutic interest.

MPhil, Aligarh Muslim University

PhD, Aligarh Muslim University

Physicians and scientists on the faculty of the Icahn School of Medicine at Mount Sinai often interact with pharmaceutical, device, biotechnology companies, and other outside entities to improve patient care, develop new therapies and achieve scientific breakthroughs. In order to promote an ethical and transparent environment for conducting research, providing clinical care and teaching, Mount Sinai requires that salaried faculty inform the School of their outside financial relationships.

Dr. Gupta has not yet completed reporting of Industry relationships.

Mount Sinai's faculty policies relating to faculty collaboration with industry are posted on our website. Patients may wish to ask their physician about the activities they perform for companies.